Published on 17 Feb 2022 on Zacks via Yahoo Finance

Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for

MacroGenics (MGNX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2021. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on February 24, 2022, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.